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http://dx.doi.org/10.1016/j.pedneo.2Objective: To evaluate the heart rate (HR) and oxygen saturation (SpO2) at 15-second intervals
within 60 seconds after incremental increases of fractional inspired oxygen (FiO2) during resus-
citation of infants younger than 29 weeks requiring two different forms of ventilatory support.
Study design: Retrospective observational study.
Methods: Forty-three infants were stabilized, 14 by continuous positive airway pressure exclu-
sively (CPAPgroup),and29bypositivepressureventilation (PPVgroup).Bothgroups receivedventi-
latory support in a special bed with two cameras enabling the evaluation of all interventions
including HR, SpO2, FiO2, positive inflation pressure, and positive end-expiratory pressure values.
FiO2wascommencedat0.30andtitrated in0.1e0.2 incrementsevery30e60seconds.Therelation-
ships between the incremental increases of FiO2 and related SpO2 andHR changeswere evaluated.
Results: Although there was an inverse correlation between initial FiO2 and SpO2 in both groups, a
significantpositive correlationbetween the incremental increaseof FiO2 and SpO2 changes after 30
seconds was found only in the CPAP group. Only higher initial levels of FiO2 had a positive effect on
the improvement in SpO2 in the PPV group.
Conclusion: The efficacy of FiO2 titration in 0.1e0.2 incrementsmay be attenuated and delayed in
extremely preterm infants required PPV during the first 6 minutes of life.
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374 T. Lamberska et albreathing spontaneously and require PPV will respond less1. Introduction
The latest recommendations of the International Liaison
Committee on Resuscitation (ILCOR) were expanded to
include the use of pulse oximetry during neonatal resusci-
tation.1 However, evidence as to the precise management
of supplemental oxygen in premature newborns is currently
lacking.
Several small, prospective randomized trials confirmed
that resuscitation of extremely premature infants (EPI) may
be initiated with lower levels of fractional inspired oxygen
(FiO2) between 0.21 and 0.40.
2e4 However, except for one
small study reporting a decrease in the incidence of bron-
chopulmonary dysplasia (BPD) in their low FiO2 group, there
is no evidence favoring these lower FiO2 values in terms of
reduction of adverse long-term outcomes.5
Wang et al,2 Escrig et al,3 and Rabi et al4 have shown in
randomized trials that it is possible to titrate administra-
tion of supplemental oxygen to oxygen saturation mea-
surements in newly born preterm infants. More than 80% of
infants initially receiving room air subsequently received
supplemental oxygen titrated to attain targeted SpO2
values.2,3,6 These cohorts included premature infants sta-
bilized on continuous positive airway pressure (CPAP) as
well as those who required positive pressure ventilation
(PPV) or intubation in the delivery room.
Oxygen treatment in a newborn will not be effective if
the infant’s lungs are not aerated, so the primary step is not
oxygen treatment but rather the establishment of func-
tional residual capacity. The strategy of oxygen tailoring, as
a secondary step to appropriate gradual oxygenation, is
based on evidence from small randomized controlled tri-
als2e4,6 and has been recommended as appropriate by ex-
perts in the field of delivery room resuscitation.7,8 The FiO2
incremental step of 0.1 every 30e60 seconds being prac-
ticed now in ongoing prospective comparative studies such
as the premature infants resuscitated with oxygen or air
(PRESOX) study and the targeted oxygenation in the
resuscitation of premature infants and their developmental
outcome (TO2RPIDO) trial. Another study, the room-air
versus oxygen administration for resuscitation of preterm
infants (ROAR) study, used bigger and quicker FiO2 incre-
ment of 0.2 every 15 seconds to reach a target saturation
range.4 Spontaneously breathing very preterm infants
immediately after delivery prolong their expiration by a
breath hold to defend lung volume.9 However, the PPV
using the frequencies of 40e60/minute recommended by
ILCOR does not allow expiratory braking.1 This pattern of
artificial breathing together with the occurrence of leaks
and obstructions may delay uniform lung aeration and
establishment of lung volume/alveolar aeration, which may
adversely influence the efficacy of supplemental oxygen.10
There are no clear clinical data that evaluate the efficacy
of incremental increases of FiO2 on the rise of HR and SpO2,
specifically when comparing two very different EPI groups,
namely (1) spontaneously breathing on CPAP exclusively,
and (2) not spontaneously breathing and requiring PPV. The
two different groups would presumably undergo different
mechanisms and dynamics in order to establish their func-
tional residual capacity. We undertook this retrospective
analysis to test the hypothesis that infants who are notwell to incremental increases in FiO2 than those who have
established a better FRC by their spontaneous respiratory
effort.
2. Objectives
The objectives of this study were to evaluate the HR and
SpO2 changes after incremental increases of FiO2 in newly
born extremely preterm infants receiving CPAP versus in-
fants receiving PPV during the first 6 minutes of life.
3. Patients and methods
This observational study was conducted at the tertiary
perinatal center of General Faculty Hospital in Prague,
where approximately 4500 infants are delivered and
approximately 140 infants <1500 g are admitted into
the neonatal intensive care unit annually. In the period
from January 2010 to February 2011, delivery room in-
terventions, heart rate, and SpO2 values were systemati-
cally collected from all inborn EPI < 29 weeks to evaluate
an internal standardized protocol for resuscitation of EPI.
This protocol had been created on a background of current
knowledge and evidence. In addition, these prospectively
collected data allowed us to analyze our strategy of FiO2
tailoring retrospectively. All the EPI were placed immedi-
ately after delivery onto a specially modified mobile
resuscitation warmer bed (ALFAMEDIC sro, Lisov, Czech
Republic) with two cameras attached to the frame. One
camera recorded all interventions that the patient was
receiving on the resuscitaire, whereas the second camera
recorded the actual time, pulse oximetry (PO) values, FiO2,
positive inflation pressure (PIP), and positive end-
expiratory pressure (PEEP). Using TRAL software sequence
analysis made it possible to concurrently evaluate both of
the recorded sequences on one screen.11 All infants were
resuscitated according to a standard protocol and algo-
rithm, and were attended by a team of two doctors and two
nurses, one of each having a minimum 10 years of neonatal
clinical experience.
3.1. Resuscitation procedure
A PO sensor was placed on the right wrist as soon as possible
and connected to a PO with a preset 2-second interval
(Radical, Masimo, California, USA). Primary settings for the
T-piecewere as follows: gas flowof 8 L/min, PIPof 26 cmH2O,
and PEEP of 5 cmH2O. The frequency of PPV in the range of
40e60/minutes was suggested and sustained inflation was
not routinely used with the initiation of PPV. CPAP provided
by a facemask was given for all infants and PPV via facemask
was only initiated if: (1) bradycardia occurred after more
than 90 seconds after cord clamping, or (2) spontaneous
breathing activity was not sufficient to achieve a target
range of SpO2 after 5 minutes of life. Intubation followed by
surfactant administration was indicatedwhen PPVwith PEEP
was required for more than 6 minutes. FiO2 was commenced
at 0.30 and was subsequently titrated in 0.1e0.20 in-
crements every 30e60 seconds if (1) the preductal SpO2
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increasing trend between 60-85% at 2e6 minutes, then be-
tween 80e93%), or (2) HR <100/minute persisted for more
than 1minute after the initiation of PPV. If bradycardia<60/
minute lasted for more than 30 seconds, a switch to the use
of FiO2 0.80 was suggested.
3.2. Data collection and statistical analysis
All FiO2 settings, HR and SpO2 values, and all interventions
were assessed and tabulated in 15-second intervals from
the collected video recordings of each patient by a single
unbiased independent physician who was not involved in
the actual resuscitations. All individual incremental in-
creases of FiO2, performed during the 6 minutes after cord
clamping, and the related changes of HR and SpO2 during
the subsequent four 15-second intervals were identified
and statistically evaluated in all patients. These data were
then compared between the two EPI groups; all infants
were divided according to the extent of ventilatory support
required: the CPAP group only received CPAP and the PPV
group received CPAP and positive pressure inflations.
Because the data were collected in 15-second intervals,
each incremental increase of FiO2 ðDFiO0e152 Þ could occur
at any time during the 15-second interval (Figure 1). The
correlation of the response between the initial HR and
SpO2 values (HR
0 and SpO02) and the resuscitator’s adjust-
ment of FiO2 ðFiO152 Þ was determined by the Spearman rank
correlation and furthermore by the Kruskal-Wallis test.
Multiple linear regression and the nonparametric Spearman
rank correlation tested the relationship between the
DFiO0e152 and HR as well as SpO2 changes over the next 60
seconds in 15-second intervals (DHR015, 030, 045, 060;
DSpO0e15; 0e30; 0e45; 0e602 ) in all infants and in the two groups
separately. The nonparametric Mann-Whitney U and Wil-
coxon tests were used to compare related changes between
the two groups of infants. The Pearson Chi-square test and
the Fisher exact test were used for categorical variables. In
post hoc analysis we used Kruskal-Wallis analysis to test the
effect of the extent of DFiO0e152 as well as the initial FiO2
levels ðFiO02Þ on related changes of DHR015, 030, 045, 060
and DSpO0e15; 0e30; 0e45; 0e602 .Figure 1 The time labels of HR and SpO2 values and changes after
were performed at any time during 360 seconds after the cord clam
each incremental increase in FiO2 (DFiO2) could be done at any ti
related values of HR and SpO2 expressed the real time interval from
intervals between were calculated. FiO2 Z fractional inspired oxy4. Results
Of the 65 EPIs <29 weeks live-born during the investiga-
tional period, 43 EPIs could be enrolled in this study
because of different technical difficulties with the extrac-
tion of the recorded data: 14 of these were supported by
facemask CPAP exclusively, followed by nasal CPAP, and the
remaining 29 required PPV (with PEEP) during the first 6
minutes of life. The basic clinical characteristics and de-
livery room interventions are summarized in Tables 1 and 2.
Only 3 of 14 infants (21%) were initially bradycardic <100/
minute in the CPAP group, although spontaneous breathing
activity was present. In infants requiring PPV, bradycardia
<100/minute and/or poor spontaneous breathing activity
was the reason for initiation of PPV at the median time
(IQR) of 114 seconds (72e150 seconds). In 18 of 29 infants
(62%), bradycardia was present in the first clear PO mea-
surement. Within the first 6 minutes of life, 731 measure-
ments of HR as well as SpO2 in 15-second intervals could be
analyzed, 493 in the PPV group and 238 in the CPAP group.
Together we found 336 of 731 hypoxemic measurements
(46%; below the 10th percentile),12 42 of 336 (12%) in
the CPAP group and 294/336 (88%) in the PPV group
(p < 0.001). Only 40 of 731 hyperoxemic measurements
(5%; SpO2 > 93%) were found in all infants, 34 of 40 (85%) in
the CPAP group and 6 of 40 (15%) in PPV group (p < 0.001).
Seventy-seven incremental increases of FiO2 were
required in 37 of the infants (86%): 26 (34%) were required
in 10 infants (71%) in the CPAP group, whereas 27 infants
(93%) in the PPV group required 51 incremental increases in
FiO2 (68%). Only seven episodes of a direct switching of FiO2
to 0.80 were identified, all of which were in the PPV
group. The characteristics of all incremental increases of
FiO2 and those related to each group are shown in Table 2.4.1. Interaction between initial HR and SpO2 values
(HR0, SpO02 ) and FiO2 adjustment ðFiO152 Þ
We found a significant negative correlation between SpO2
0
and FiO152 values but not between HR
0 and FiO152 levels in
both groups (rZ0.214, p< 0.001; rZ0.572, p< 0.001).incremental increases of FiO2. All incremental increases of FiO2
ping. Because the data were collected in 15-second intervals,
me during the first 15-second interval. The assigned labels for
the time 0 and changes (D) in HR and SpO2 are labeled by time
gen; HR Z heart rate; SpO2 Z oxygen saturation.
Table 1 Characteristics of infants.
All infants
(n Z 43)
CPAP group
(n Z 14)
PPV group
(n Z 29)
Gestational age, mean (SD), wk 26.6 (1.8) 27.5 (0.7)a 26.1 (1.9)*
Birthweight, mean (SD), g 815 (240) 863 (236) 793 (238)
Male 14 (33) 4 (29) 10 (34)
Full course of antenatal steroids 22 (51) 10 (71) 12 (41)**
Cesarean section 36 (84) 13 (93) 23 (79)
General anesthesia 20 (47) 5 (36) 15 (52)
Placental transfusion (milking) 19 (44) 5 (36) 14 (48)
Multiple birth 12 (28) 2 (14) 10 (34)
Died before discharge 5 (12) 0 5 (17)
Apgar score at 1 min 5 (4e6) 7 (6e8) 4 (2e6)*
Apgar score at 5 min 6 (5e8) 9 (8e9) 6 (5e7)*
HR at 5 min, bpm 135 (122e152) 147 (135e156) 132 (103e149)*
SpO2 at 5 min, % 75 (49e85) 87 (78e92) 57 (41e77)*
Time of HR  120 bpm achievement, sec 150 (97e277) 105 (90e142) 225 (120e315)*
Time of SpO2  80% achivement, sec 390 (247e555) 225 (165e277) 420 (330e660)*
Data are presented as n (%) or median (IQR), unless otherwise indicated.
*p < 0.01, Mann-Whitney U test.
**p Z 0.064,c2 test.
Bpm Z beats per minute; HR Z heart rate; IQR Z interquartile range; SD Z standard deviation; SpO2 Z saturation of oxygen.
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lower the SpO2
0 values, the higher the FiO152 level s used in
both groups (p < 0.001). This was not true for the different
values of HR0 and related levels of FiO152 .
4.2. Correlation between the incremental
increases in FiO2 ðDFiO0e152 Þ and the subsequent HR
and SpO2 changes in 15-second intervals (DHR
0L15,
0L30, 0L45, 0L60 and DSpO0e15; 0e30; 0e45; 0e602 )
No significant correlation was found between all DFiO0e152
and the subsequent DHR015, 030, 045, 060 and
DSpO0e15; 0e30; 0e45; 0e602 in all infants by Spearman rank cor-
relation test.When the relationshipswere correlated for each
group separately, a significant correlation between the
DFiO0e152 and DSpO
0e45
2 as well as DSpO
0e60
2 was found only in
theCPAPgroup (rZ0.41and rZ0.51, respectively,p<0.05).
4.3. FiO2 levels prior to and after incremental
increases of FiO2 ðFiO0; 15; 30; 45; 602 Þ and related
values of heart rate and saturation of oxygen in 15-
second intervals (HR0, 15, 30, 45, 60; SpO0; 15; 30; 45; 602 )
Significantly higher FiO0; 15; 30; 45; 602 levels were administered
in the PPV group and lower related values of HR0, 15, 30, 45, 60
and SpO0; 15; 30; 45; 602 were found at each time point
(p < 0.01). The mean [Standard Deviation (SD)] FiO152 level
was significantly higher than mean (SD) FiO02 in both groups
[0.31 (0.11) vs. 0.42 (0.15), p < 0.01; 0.40 (0.15) vs. 0.55
(0.18), p < 0.001]; however, only average (SD) SpO452 and
SpO602 values in the CPAP group were significantly higher in
comparison with SpO2
0 [56% (18) vs. SpO452 68% (17), and SpO
60
2
72% (16), p < 0.01; Figure 2. The significance of differences
between the CPAP and the PPV groups in extent of incre-
mental increases of FiO2 and related changes of HR and SpO2
are summarized in Table 3.4.4. Post hoc analysis in PPV group
Despite the nonsignificant correlation between the
DFiO0e152 and related DHR
015, 030, 045, 060 and
DSpO0e15; 0e30; 0e45; 0e602 that was found in the group of in-
fants supported by PPV, further Kruskal-Wallis analysis was
completed to test if any independent variables such as the
extent of DFiO0e152 and the initial levels of FiO
0
2, HR
0, or SpO02
may have had a positive effect on the DHR015, 030, 045,
060 and DSpO0e15; 0e30; 0e45; 0e602 as the dependent variables.
The significances between those relations are introduced in
Table 3. The lower HR0 and SpO02 values increased signifi-
cantly (pZ 0.007 and pZ 0.002) more than values closer to
normal, but without any relation to the FiO2
0 level or to the
extent of the incremental increase of FiO2. Higher FiO
0
2 level
tested from mean (SD) level from 0.30 (0.00) to 0.62 (0.08)
had a significant positive effect on SpO2 rise (pZ 0.002) and
this initial dose-dependent effect was also positively time-
related (p Z 0.010). Larger DFiO0e152 tested from mean
(SD) level of 0.05 (0.08) up to 0.37 (0.08) had a borderline
significance on a positive rise of SpO2 (p Z 0.049).
5. Discussion
During the transition from placental to lung breathing the
establishment and the maintenance of alveolar expansion is
the first step to oxygenation. This is a dynamic process
following delivery and may be influenced by intrinsic vari-
ables such as lung maturation, prenatal infection, and the
level of spontaneous breathing activity, as well as by
extrinsic variables such as the level of the resuscitator’s
skill, iatrogenic airway obstruction, and mask leak.
This observational study shows the different efficacy of
incremental increases in FiO2 in the two groups of
extremely preterm infants with different levels of
Table 2 Delivery room interventions.
All infants
(n Z 43)
CPAP group
(n Z 14)
PPV group
(n Z 29)
p
Time to first PO data 87 (70e110) 85 (74e101) 95 (70e162) 0.218
CPAP start sec postpartum 72 (50e98) 94 (64e120) 65 (47e90) 0.157
PPV start sec postpartum 114 (72e150) 0 114 (72e150)
PPV end sec postpartum 339 (250e414) 0 339 (250e414)
Sustained inflation maneuver 5 (12) 0 5 (17) 0.272
Intubation in DR 15 (35) 0 15 (52) 0.003
Intubation start sec postpartum, sec 378 (348e389) 0 378 (348e389)
Intubation end sec postpartum 450 (444e759) 0 450 (444e759)
Surfactant administered in DR 15 (35) 0 15 (35) 0.003
Time of surfactant administration, sec 713 (523e881) 0 713 (523e881)
Infants with FiO2 1.0 4 (9) 0 4 (14) 0.319
Infants with incremental increases of FiO2 37(86) 10 (71) 27 (93) 0.074
Incremental increases of FiO2, n 77 26 51 0.185
FiO2 level before incremental increase, mean (SD) 0.37 (0.16) 0.31 (0.11) 0.40 (0.15) 0.009
FiO2 level after incremental increase, mean (SD) 0.51 (0.20) 0.42 (0.15) 0.55 (0.18) 0.006
Time of FiO2 incremental increases, sec 195 (145e259) 165 (120e255) 195 (150e270) 0.001
Data are presented as n (%) or median (IQR), unless otherwise indicated.
CPAP Z continuous positive airway pressure; DR Z delivery room; FiO2 Z fractional inspiratory oxygen; IQR Z interquartile range;
p Z Mann-Whitney U test; PO Z pulse dosimeter; PPV Z positive pressure ventilation.
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of ventilatory support to establish their functional residual
capacity during the first 6 minutes of life.
We found that the incremental increases of FiO2 had a
significant effect on the improvement in SpO2 within 45
seconds when the infants were breathing spontaneously on
facemask CPAP only. In this group of infants, 18% (42 of 238)
of the 15-second interval measurements of SpO2 were
below the 10th percentile and 14% (34 of 238) of mea-
surements had SpO2 > 93%. Nearly 70% of the measure-
ments of SpO2 were within target range (the 25the75th
percentile of SpO2 nomogram) during the first 6 minutes of
life.12 Interestingly, in this small CPAP group of extremely
premature infants, the medians and IQRs of HR and SpO2 at
5 minutes correspond very closely to the reference ranges
according to Dawson et al12 [147 beats per minute (bpm);
(135e156) vs. 156 (142e171); 87% (78e92) vs. 86% (80e92)],
where 468 neonates with gestational ages from 25 weeks to
42 weeks (only 24% of preterm infants <32 weeks) without
any DR interventions were recruited. In a recently pub-
lished study, Vento et al13 showed that well-adapted
spontaneously breathing very preterm infants can be
managed with CPAP via facemask with air and achieve the
SpO2 reference ranges of Dawson et al’s
12 nomograms even
earlier. Spontaneously breathing very preterm infants pro-
long their expiration by braking their expiratory flow
against a closed or narrowed glottis and thus increase
intrapulmonary pressure above atmospheric pressure. This
biological force facilitates the clearing of fluid from the
lung, resulting in better distribution of gas and opening of
the alveoli.9 This finding is consistent with the good SpO2
response after incremental FiO2 increases in our CPAP
group. Despite the small sample size of our CPAP group, we
think that a certain proportion of extremely premature
infants with some spontaneous breathing effort can also be
safely managed by CPAP via mask during the first minutes oflife with effective gentle tailoring of FiO2 and achieve the
same reference ranges of oxygen saturation as the more
mature infants.
The incremental increases of FiO2 did not, however, in-
crease either SpO2 or HR values significantly in the infants
who had poor spontaneous breathing activity requiring PPV
despite the higher mean level of FiO2 prior to incremental
increase to an even larger extent. These differences in FiO2
tailoring could be explained by mostly larger incremental
increases of FiO2 performed by specialists in the recom-
mended range of 0.1e0.2 (14% of them were identified as
the direct switches to FiO2  0.8). The longer median time
of mean FiO2 incremental increases in PPV group corre-
sponds well with the chronological order of our in-
terventions described in resuscitation procedure. First,
CPAP via mask was switched to PPV and then the first in-
cremental increase of FiO2 followed if bradycardia per-
sisted. In this group of infants, 60% (294 of 493) of the SpO2
measurements were below the 10th percentile during the
first 6 minutes of life.12 These infants did not respond well
to facemask PPV managed by our specialists and finally 41%
of them required intubation at the median time (IQR) of 378
(348e389) seconds after delivery. They were significantly
more immature, had a lower rate of full antenatal steroid
treatment, and had lower Apgar scores at the 1st minute
and 5th minute.
In a post hoc analysis the larger extent of the incre-
mental increases of FiO2 was found effective in improving
oxygenation with a borderline significance, but when higher
initial levels of FiO2 were used the significantly larger SpO2
changes were found. This dose-related effect of the initial
level of FiO2 is also time-related and the synergic effect of
a higher dose of oxygen and advanced lung aeration may
play a role in better oxygenation. These findings correspond
well with the significantly longer time needed to achieve
stable HR and SpO2 in this group of EPI. The PPV using
Table 3 Significance of differences between continuous
positive airway pressure and positive pressure ventilation
groups in extents (D) of incremental increases of fractional
inspired oxygen and related changes (D) of heart rate and
saturation of oxygen during investigational period (Mann-
Whitney U test).*
1500 3000 4500 6000 0e6000
DFiO2 0.019 0.455 0.280 0.195 0.007
DHR, bpm 0.233 0.120 0.021 0.095 0.140
DSpO2, % 0.175 0.490 0.010 0.499 0.011
Bpm Z beats per minute; FiO2 Z fractional inspired oxygen;
HR Z heart rate; SpO2 Z oxygen saturation.
* Although significantly higher incremental increases in FiO2
were performed in the positive pressure ventilation (PPV)
group, the significantly higher changes in SpO2 were found in
the continuous positive airway pressure group, which was
mainly recognized between 30-second and 45-second intervals
after FiO2 increase. In the same time interval, the HR changes
were significantly higher in the PPV group but it was not
confirmed during the entire investigational period.
Figure 2 Initial FiO2 levels prior to and after incremental
increases of FiO2 and related HR and SpO2 values at each time
point within 1 minute in both groups. (A) Values of
FiO0; 15; 30; 45; 602 in the CPAP group (triangles) and in the PPV
group (squares); (B) related HR0, 15, 30, 45, 60 and (C)
SpO0; 15; 30; 45; 602 values. Mann-Whitney U testing found signifi-
cant differences between the two groups in independent and
both dependent variables at each time point of investigation
(p < 0.01). The values are mean with standard deviations.
CPAPZ continuous positive airway pressure; FiO2Z fractional
inspired oxygen; HR Z heart rate; PPV Z positive pressure
ventilation; SpO2 Z oxygen saturation.
378 T. Lamberska et alfrequencies of 40e60/minute recommended by ILCOR does
not allow expiratory braking as spontaneous breathing.1
Manual inflations were performed mostly with a short
inflation time, sometimes interrupted by repositioning of
the facemask, thereby losing PEEP. The T-piece device was
used without changes in the preset pressure and a crossover
to self-inflating bag ventilation was not practiced during
the first 6 minutes of life. This pattern of artificial
breathing together with the common occurrence of leaks
and obstructions may delay uniform lung aeration and the
establishment of lung volume, which may adversely influ-
ence the efficacy of supplemental oxygen.10 Fuchs et al14
have shown that a sustained inflation can increase HR
rapidly and SpO2 with slight delay in apneic infants. How-
ever, infants in our study did not routinely receive a sus-
tained inflation. Three of five patients increased their HR
within 1 minute after one unrepeated 10-second inflation of
25 cmH2O.
There are several limitations to this study. The infants in
the PPV group were more immature, smaller, and sicker and
their lungs might have been less developed than those in
the CPAP group and required more ventilatory support with
poor response to the incremental increases of FiO2.
The observational retrospective design of this study does
not allow identification of the precise time of incremental
increases in FiO2 performed during the 15-second interval.
That means that each incremental increase of FiO2 could
have occurred anytime during this 15-second interval and
the subsequent HR and SpO2 changes are related to this 15-
second interval and not to the actual time of the FiO2 in-
crease. We think that the 45e60-second interval should be
long enough for the final evaluation of the effect of oxygen
changes. Vento et al5 and Dawson et al6 considered an
interval of at least 30 seconds to be adequate for the eval-
uation of the potential effect of oxygen changes. It corre-
sponds well with the 30e45-second time interval during
which the first significant related changes of SpO2 were
found in our infants who responded well in our CPAP group.
Furthermore, because obstruction and leak episodes
were not measured in our study, we cannot comment on
The efficacy of FiO2 increase 379whether the attenuated effect of the oxygen increases was
caused primarily by the delayed aeration of the lungs in the
poorly spontaneously breathing infants or due to the effects
of such obstructions and/or leaks.
Another limitation is that PPV was only initiated if
bradycardia was present after 90 seconds or target satu-
rations were not reached by 5 minutes. It is possible that
earlier initiation of PPV in infants with marginal respiratory
effort might be more effective in establishing functional
residual capacity and might lead to a better response to
incremental increase of FiO2.
In conclusion, spontaneous breathing, supported by
continuous distending pressure, appears to be the best
condition for adequate lung aeration resulting in gradual
improvement of oxygenation. These infants can be
managed effectively by “gentle” tailoring of FiO2 in in-
crements of 0.1e0.2 in 30e45-second intervals.
However, when PPV was required in more immature in-
fants who were not initially spontaneously breathing, a
much higher incremental increase in FiO2 was required to
improve oxygenation.
Establishment of adequate functional residual capacity
should be the primary aim during the first minutes of life in
extremely premature infants. The technique of facemask
positive pressure ventilation used in this study, which is
based on the last ILCOR recommendation, did not achieve
adequate lung volume recruitment. Further studies are
required in order to determine best ways of lung volume
recruitment in infants lacking spontaneous respiratory
effort and to accurately guide the administration of FiO2
during the resuscitation of extremely preterm infants based
on the degree of spontaneous respiratory activity.
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